menu
    • menu

    Find Ambrisentan manufacturers, exporters & distributors on PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    21

    API Suppliers

    API Suppliers

    10

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    2

    JDMF

    JDMFs Filed

    7

    EU WC

    EU WC

    1

    KDMF

    KDMF

    6

    NDC API

    NDC API

    0

    VMF

    NDC API

    11

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 33,060

    MARKET PLACE

    6

    API

    5

    FDF

    4INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    102

    FDF Dossiers

    FDF Dossiers

    20

    FDA Orange Book

    FDA (Orange Book)

    32

    Europe

    Europe

    8

    Canada

    Canada

    32

    Australia

    Australia

    4

    South Africa

    South Africa

    6

    Listed Dossiers

    Listed Dossiers

    3DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    6

    US Patents

    0

    US Exclusivities

    6

    Health Canada Patents

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    14

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    350,219,632

    Annual Reports

    4,734

    Finished Drug Prices

    Listed Dossiers

    108 RELATED EXCIPIENT COMPANIES

    172EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 177036-94-1, Letairis, Volibris, Lu-208075, Bsf 208075, Bsf-208075
    Molecular Formula
    C22H22N2O4
    Molecular Weight
    378.4  g/mol
    InChI Key
    OUJTZYPIHDYQMC-LJQANCHMSA-N
    FDA UNII
    HW6NV07QEC
    Ambrisentan
    Ambrisentan is an orally bioavailable, selective antagonist of the endothelin type-A (ETA) receptor that may be used for the treatment of pulmonary arterial hypertension (PAH). Upon administration, ambrisentan targets and binds to ETA receptor, which prevents the binding of endothelin-1 (ET-1) to the ETA receptor and ET-1/ETA-mediated vasoconstriction and cell proliferation. This may lead to vasodilation. ET-1 concentrations are increased in plasma as well as lung tissue in PAH, and ET-1 may play a key role in the pathogenesis of PAH.
    Ambrisentan is an Endothelin Receptor Antagonist. The mechanism of action of ambrisentan is as an Endothelin Receptor Antagonist.
    1 2D Structure

    Ambrisentan

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid
    2.1.2 InChI
    InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1
    2.1.3 InChI Key
    OUJTZYPIHDYQMC-LJQANCHMSA-N
    2.1.4 Canonical SMILES
    CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
    2.1.5 Isomeric SMILES
    CC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
    2.2 Other Identifiers
    2.2.1 UNII
    HW6NV07QEC
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (+)-(2s)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic Acid

    2. (+)-ambrisentan

    3. (+-)-ambrisentan

    4. (-)-ambrisentan

    5. (r)-ambrisentan

    6. (s)-ambrisentan

    7. Ambrisentan, (+-)-

    8. Ambrisentan, (-)-

    9. Ambrisentan, (r)-

    10. Bsf 208075

    11. Bsf-208075

    12. Bsf208075

    13. Gsk 1325760

    14. Gsk 1325760a

    15. Gsk-1325760

    16. Gsk-1325760a

    17. Gsk1325760

    18. Gsk1325760a

    19. Letairis

    20. Lu 208075

    21. Lu-208075

    22. Lu208075

    23. Volibris

    2.3.2 Depositor-Supplied Synonyms

    1. 177036-94-1

    2. Letairis

    3. Volibris

    4. Lu-208075

    5. Bsf 208075

    6. Bsf-208075

    7. Lu 208075

    8. (s)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic Acid

    9. (s)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic Acid

    10. (2s)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic Acid

    11. Gsk1325760a

    12. Gsk-1325760a

    13. Hw6nv07qec

    14. Gsk1325760

    15. Gsk-1325760

    16. Chembl1111

    17. Dsstox_cid_26282

    18. Dsstox_rid_81508

    19. Dsstox_gsid_46282

    20. Ambrisentan [inn]

    21. Lu208075

    22. (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic Acid

    23. (s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic Acid

    24. Cas-177036-94-1

    25. Unii-hw6nv07qec

    26. Ambrisentan [inn:ban:jan]

    27. Ncgc00160662-01

    28. Letairis (tn)

    29. Volibris (tn)

    30. Ambrisentan- Bio-x

    31. Ambrisentan (jan/inn)

    32. Ambrisentan [mi]

    33. Ambrisentan [jan]

    34. Ambrisentan [vandf]

    35. Schembl3679

    36. Ambrisentan [mart.]

    37. Ambrisentan [who-dd]

    38. Ambrisentan, (+)-

    39. Mls006010218

    40. Ambrisentan [ema Epar]

    41. Gtpl3951

    42. Dtxsid4046282

    43. Ambrisentan [orange Book]

    44. Chebi:135949

    45. Zinc538627

    46. Ex-a3315

    47. Tox21_111967

    48. Bdbm50146710

    49. Fd7219

    50. Mfcd09842330

    51. S2097

    52. Akos015994540

    53. Tox21_111967_1

    54. Ac-9015

    55. Ccg-268386

    56. Cs-0447

    57. Db06403

    58. De-0223

    59. (+)-(2s)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic Acid

    60. (+-)-(2s)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic Acid

    61. Ncgc00160662-02

    62. Ncgc00346730-01

    63. Ba164153

    64. Benzenepropanoic Acid, Alpha-[(4,6-dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-, (alphas)-

    65. Hy-13209

    66. Smr004701307

    67. Sw219060-1

    68. D07077

    69. Ab01566890_01

    70. Q410789

    71. J-519579

    72. (?s)-?-[(4,6-dimethyl-2-pyrimidinyl)oxy]-?-methoxy-?-phenylbenzenepropanoic Acid

    73. (2s)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic Acid

    74. (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic Acid

    75. (s)-2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic Acid

    2.4 Create Date
    2006-07-28
    3 Chemical and Physical Properties
    Molecular Weight 378.4 g/mol
    Molecular Formula C22H22N2O4
    XLogP33.8
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count7
    Exact Mass378.15795719 g/mol
    Monoisotopic Mass378.15795719 g/mol
    Topological Polar Surface Area81.5 Ų
    Heavy Atom Count28
    Formal Charge0
    Complexity475
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Ambrisentan is indicated for treatment of idiopathic (primary) pulmonary arterial hypertension (IPAH) and pulmonary arterial hypertension (PAH) associated with connective tissue disease in patients with WHO functional class II or III symptoms. In the United States of America, ambrisentan is also indicated in combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability.

    FDA Label

    Ambrisentan Mylan is indicated for the treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment. Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.

    Ambrisentan Mylan is indicated for the treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment. Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.

    Volibris is indicated for treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment (see section 5. 1). Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.

    Volibris is indicated for treatment of PAH in adolescents and children (aged 8 to less than 18 years) of WHO Functional Class (FC) II to III including use in combination treatment. Efficacy has been shown in IPAH, familial, corrected congenital and in PAH associated with connective tissue disease (see section 5. 1).

    Pulmonary arterial hypertension

    Treatment of pulmonary arterial hypertension

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Ambrisentan 10 mg daily had no significant effect on the QTc interval, whereas a 40 mg daily dose of ambrisentan increased mean QTc at tmax by 5 ms with an upper 95% confidence limit of 9 ms. Significant QTc prolongation is not expected in patients taking ambrisentan without concomitant metabolic inhibitors. Plasma concentrations of B-type natriuretic peptide (BNP) in patients who received ambrisentan for 12 weeks were significantly decreased. Two Phase III placebo-controlled studies demonstrated a decrease in BNP plasma concentrations by 29% in the 2.5 mg group, 30% in the 5 mg group, and 45% in the 10 mg group (p < 0.001 for each dose group) and an increase by 11% in the placebo group.

    5.2 MeSH Pharmacological Classification

    Antihypertensive Agents

    Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    AMBRISENTAN
    5.3.2 FDA UNII
    HW6NV07QEC
    5.3.3 Pharmacological Classes
    Endothelin Receptor Antagonists [MoA]; Endothelin Receptor Antagonist [EPC]
    5.4 ATC Code

    C02KX02

    C02KX02

    C02KX02

    S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

    C - Cardiovascular system

    C02 - Antihypertensives

    C02K - Other antihypertensives

    C02KX - Antihypertensives for pulmonary arterial hypertension

    C02KX02 - Ambrisentan

    5.5 Absorption, Distribution and Excretion

    Absorption

    Ambrisentan is rapidly absorbed with peak plasma concentrations occuring around 2 hours after oral administration. Cmax and AUC increase proportionally with dose across the therapeutic dosing range. Absolute oral bioavailability of ambrisentan is unknown. Absorption is not affected by food.

    Route of Elimination

    Ambrisentan is primarily cleared by non-renal pathways. Along with its metabolites, ambrisentan is primarily found in the feces following hepatic and/or extra-hepatic metabolism. Approximately 22% of the administered dose is recovered in the urine following oral administration with 3.3% being unchanged ambrisentan.

    Volume of Distribution

    Ambrisentan has a low distribution into red blow cells, with a mean blood:plasma ratio of 0.57 and 0.61 in males and females, respectively.

    Clearance

    The mean oral clearance of ambrisentan was found to be 38 mL/min in healthy subjects and 19 mL/min in patients with pulmonary artery hypertension.

    5.6 Metabolism/Metabolites

    Ambrisentan is a metabolized primarily by uridine 5-diphosphate glucuronosyltransferases (UGTs) 1A9S, 2B7S,1A3S to form ambrisentan glucuronide. Ambrisentan is also metabolized to a lesser extent by CYP3A4, CYP3A5 and CYP2C19 to form 4- hydroxymethyl ambrisentan which is further glucuronidated to 4-hydroxymethyl ambrisentan glucuronide.

    5.7 Biological Half-Life

    Ambrisentan has a terminal half-life of 15 hours. It is thought that steady state is achieved after around 4 days of repeat-dosing.

    5.8 Mechanism of Action

    Endothelin-1 (ET-1) is an endogenous peptide that acts on the endothelin type A (ETA) and endothelin type B (ETB) receptors in vascular smooth muscle and endothelium. ETA-mediated actions include vasoconstriction and cell proliferation, whereas ETB predominantly mediates vasodilation, anti-proliferation, and ET-1 clearance. In patients with pulmonary arterial hypertension, ET-1 levels are increased and correlate with increased right arterial pressure and severity of disease. Ambrisentan is one of several newly developed vasodilator drugs that selectively target the endothelin type A (ETA) receptor, inhibiting its action and preventing vasoconstriction. Selective inhibition of the ETA receptor prevents phospholipase C-mediated vasoconstriction and protein kinase C-mediated cell proliferation. Endothelin type B (ETB) receptor function is not significantly inhibited, and nitric oxide and prostacyclin production, cyclic GMP- and cyclic AMP-mediated vasodilation, and endothelin-1 (ET-1) clearance is preserved.

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627929000,"product":"AMBRISENTAN (TAX INVOICE NO:1900215472 D ATE:30.07.2021","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"TOKYO - NARITA","customer":"CBC GROUP","customerCountry":"JAPAN","quantity":"0.97","actualQuantity":"0.97","unit":"KGS","unitRateFc":"50898.8","totalValueFC":"47962.2","currency":"USD","unitRateINR":3667254.6391752576,"date":"03-Aug-2021","totalValueINR":"3557237","totalValueInUsd":"47962.2","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"3590612","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1630953000,"product":"AMBRISENTAN (TAX INV NO:1900215651, DT:3","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"GAVA AIRFARM LOGISTICS ","customerCountry":"UNITED ARAB EMIRATES","quantity":"0.03","actualQuantity":"30","unit":"GMS","unitRateFc":"30","totalValueFC":"802.1","currency":"USD","unitRateINR":1966.6666666666667,"date":"07-Sep-2021","totalValueINR":"59000","totalValueInUsd":"802.1","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"4431138","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1636569000,"product":"AMBRISENTAN","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"BAGDAD, METROPOLITAN","customer":"SAMA ALFAYHAA PHARMACEUTICAL ","customerCountry":"IRAQ","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"50000","totalValueFC":"4847.5","currency":"USD","unitRateINR":3610000,"date":"11-Nov-2021","totalValueINR":"361000","totalValueInUsd":"4847.5","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"5921049","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"IRAQ","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637519400,"product":"AMBRISENTAN","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"LAB. ASPEN S.A","customerCountry":"ARGENTINA","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"30","totalValueFC":"2605","currency":"USD","unitRateINR":1940,"date":"22-Nov-2021","totalValueINR":"194000","totalValueInUsd":"2605","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"6184656","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1642617000,"product":"OTHER ORGANIC COMPOUNDS-AMBRISENTAN","address":"SETHNA BUILDING 4TH FLOOR 55,MAHAR SHI KARVE ROAD MARINE LINE","city":"MUMBAI,MAHARASHTRA","supplier":"MEGAFINE PHARMA (P) LIMITED","supplierCountry":"INDIA","foreign_port":"BOGOTA","customer":"TO THE ORDER OF,","customerCountry":"COLOMBIA","quantity":"0.93","actualQuantity":"0.925","unit":"KGS","unitRateFc":"28000","totalValueFC":"25559.3","currency":"USD","unitRateINR":2058378.3783783782,"date":"20-Jan-2022","totalValueINR":"1904000","totalValueInUsd":"25559.3","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"7615355","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"COLOMBIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"SETHNA BUILDING 4TH FLOOR 55,MAHAR SHI KARVE ROAD MARINE LINE, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648146600,"product":"AMBRISENTAN(1X30 GM SAMPLE HDPE DRUM SEN","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"TOKYO - NARITA","customer":"CBC GROUP","customerCountry":"JAPAN","quantity":"1.80","actualQuantity":"1.8","unit":"KGS","unitRateFc":"50000","totalValueFC":"88625.6","currency":"USD","unitRateINR":3752777.7777777775,"date":"25-Mar-2022","totalValueINR":"6755000","totalValueInUsd":"88625.6","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"9197837","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659378600,"product":"AMBRISENTAN","address":"PLOT NO.35, IDA,,BALANAGAR,","city":"HYDERABAD,TELANGANA","supplier":"LAUREL PHARMA LABS","supplierCountry":"INDIA","foreign_port":"BUDAPEST,","customer":"TO THE ORDER OF","customerCountry":"HUNGARY","quantity":"0.00","actualQuantity":"4","unit":"GMS","unitRateFc":"1050","totalValueFC":"4185.1","currency":"USD","unitRateINR":83250,"date":"02-Aug-2022","totalValueINR":"333000","totalValueInUsd":"4185.1","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"3237973","productDescription":"API","marketType":"REGULATED MARKET","country":"HUNGARY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.35, IDA,,BALANAGAR,, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1664217000,"product":"AMBRISENTAN USDMF - BATCH NO: HDP220107","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SHANGHAI - PU DONG","customer":"GUANGDONG ZESHENG PHAR.CO.,LTD","customerCountry":"CHINA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"45000","totalValueFC":"13239.2","currency":"USD","unitRateINR":3536666.666666667,"date":"27-Sep-2022","totalValueINR":"1061000","totalValueInUsd":"13239.2","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"4473925","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683225000,"product":"MSN PHARMACEUTICALS PRODUCT NAME AMBRISENTAN","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"FRANKFURT MAIN INT L","customer":"TO THE ORDER","customerCountry":"GERMANY","quantity":"0.35","actualQuantity":"0.35","unit":"KGS","unitRateFc":"25000","totalValueFC":"8519.3","currency":"USD","unitRateINR":2002857.142857143,"date":"05-May-2023","totalValueINR":"701000","totalValueInUsd":"8519.3","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708540200,"product":"PHARMACEUTICAL RAW MATERIAL AMBRISENTAN","address":"1706,17TH FL KESAR SOLITAIRE PLOT","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"TO ORDER","customerCountry":"ARGENTINA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"60000","totalValueFC":"17639.9","currency":"USD","unitRateINR":4878844,"date":"22-Feb-2024","totalValueINR":"1463653.2","totalValueInUsd":"17639.9","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"7732576","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"1706,17TH FL KESAR SOLITAIRE PLOT, NAVI MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720981800,"product":"AMBRISENTAN STANDARD (500MG) BATCH NO.MLS-ABS-STD\/001","address":"CAMUS HOUSE, 29-B,","city":"JAIPUR, RAJASTHAN.","supplier":"CAMUS PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"PSK PHARMA LTD.","customerCountry":"RUSSIA","quantity":"0.00","actualQuantity":"0.5","unit":"GMS","unitRateFc":"23000","totalValueFC":"134.7","currency":"INR","unitRateINR":22526.400000000001,"date":"15-Jul-2024","totalValueINR":"11263.2","totalValueInUsd":"134.7","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"2414025","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"CAMUS HOUSE, 29-B,, JAIPUR, RAJASTHAN.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725561000,"product":"AMBRISENTAN","address":"1706,17TH FL KESAR SOLITAIRE PLOT","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"TO ORDER","customerCountry":"ARGENTINA","quantity":"0.90","actualQuantity":"0.9","unit":"KGS","unitRateFc":"60000","totalValueFC":"53425.2","currency":"USD","unitRateINR":4974555.555555555,"date":"06-Sep-2024","totalValueINR":"4477100","totalValueInUsd":"53425.2","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"3824611","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"1706,17TH FL KESAR SOLITAIRE PLOT, NAVI MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1728325800,"product":"ACTIVE PHARMACEUTICAL INGREDIENTS - OTHER ORGANIC CHEMICAL COMPOUNDS: AMBRISENTAN","address":"SETHNA BUILDING, 4TH FLR,","city":"LINES, MUMBAI ,MAHARASHTRA","supplier":"MEGAFINE PHARMA (P) LIMITED","supplierCountry":"INDIA","foreign_port":"DA NANG","customer":"TO THE ORDER OF","customerCountry":"VIETNAM","quantity":"0.33","actualQuantity":"0.33","unit":"KGS","unitRateFc":"24400","totalValueFC":"7716","currency":"USD","unitRateINR":1964685.4545454544,"date":"08-Oct-2024","totalValueINR":"648346.2","totalValueInUsd":"7716","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4684716","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"VIETNAM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"SETHNA BUILDING, 4TH FLR,, LINES, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708453800,"product":"AMBRISENTAN (QTY : 1 X 0.4 GMS, VALUE USD: 23.81)(FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"USP","supplierCountry":"CHINA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0004","unit":"KGS","unitRateFc":"59525","totalValueFC":"29.2","currency":"USD","unitRateINR":"6049150","date":"21-Feb-2024","totalValueINR":"2419.66","totalValueInUsd":"29.2","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"2235120","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD 21704 USA Frederick, , United States United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708453800,"product":"AMBRISENTAN (QTY : 1 X 0.5 GMS, VALUE USD: 26.51)(FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"USP","supplierCountry":"CHINA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0005","unit":"KGS","unitRateFc":"53020","totalValueFC":"32.5","currency":"USD","unitRateINR":"5388100","date":"21-Feb-2024","totalValueINR":"2694.05","totalValueInUsd":"32.5","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"2235120","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD 21704 USA Frederick, , United States United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708453800,"product":"AMBRISENTAN (QTY : 1 X 1.2 GMS, VALUE USD: 45.42)(FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"USP","supplierCountry":"CHINA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0012","unit":"KGS","unitRateFc":"37850","totalValueFC":"55.6","currency":"USD","unitRateINR":"3846466.7","date":"21-Feb-2024","totalValueINR":"4615.76","totalValueInUsd":"55.6","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"2235120","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD 21704 USA Frederick, , United States United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708453800,"product":"AMBRISENTAN (QTY : 2 X 0.2 GMS, VALUE USD: 18.41\/EACH)(FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"USP","supplierCountry":"CHINA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0004","unit":"KGS","unitRateFc":"92050","totalValueFC":"45.1","currency":"USD","unitRateINR":"9354475","date":"21-Feb-2024","totalValueINR":"3741.79","totalValueInUsd":"45.1","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"2235120","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD 21704 USA Frederick, , United States United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"}]
    03-Aug-2021
    08-Oct-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Granulation

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Topical

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    ABOUT THIS PAGE

    Ambrisentan Manufacturers

    A Ambrisentan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ambrisentan, including repackagers and relabelers. The FDA regulates Ambrisentan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ambrisentan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Ambrisentan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Ambrisentan Suppliers

    A Ambrisentan supplier is an individual or a company that provides Ambrisentan active pharmaceutical ingredient (API) or Ambrisentan finished formulations upon request. The Ambrisentan suppliers may include Ambrisentan API manufacturers, exporters, distributors and traders.

    click here to find a list of Ambrisentan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Ambrisentan USDMF

    A Ambrisentan DMF (Drug Master File) is a document detailing the whole manufacturing process of Ambrisentan active pharmaceutical ingredient (API) in detail. Different forms of Ambrisentan DMFs exist exist since differing nations have different regulations, such as Ambrisentan USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Ambrisentan DMF submitted to regulatory agencies in the US is known as a USDMF. Ambrisentan USDMF includes data on Ambrisentan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ambrisentan USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Ambrisentan suppliers with USDMF on PharmaCompass.

    Ambrisentan JDMF

    The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

    The Ambrisentan Drug Master File in Japan (Ambrisentan JDMF) empowers Ambrisentan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

    PMDA reviews the Ambrisentan JDMF during the approval evaluation for pharmaceutical products. At the time of Ambrisentan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

    click here to find a list of Ambrisentan suppliers with JDMF on PharmaCompass.

    Ambrisentan KDMF

    In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

    Pharmaceutical companies submit a Ambrisentan Drug Master File in Korea (Ambrisentan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ambrisentan. The MFDS reviews the Ambrisentan KDMF as part of the drug registration process and uses the information provided in the Ambrisentan KDMF to evaluate the safety and efficacy of the drug.

    After submitting a Ambrisentan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ambrisentan API can apply through the Korea Drug Master File (KDMF).

    click here to find a list of Ambrisentan suppliers with KDMF on PharmaCompass.

    Ambrisentan WC

    A Ambrisentan written confirmation (Ambrisentan WC) is an official document issued by a regulatory agency to a Ambrisentan manufacturer, verifying that the manufacturing facility of a Ambrisentan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ambrisentan APIs or Ambrisentan finished pharmaceutical products to another nation, regulatory agencies frequently require a Ambrisentan WC (written confirmation) as part of the regulatory process.

    click here to find a list of Ambrisentan suppliers with Written Confirmation (WC) on PharmaCompass.

    Ambrisentan NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ambrisentan as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Ambrisentan API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Ambrisentan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Ambrisentan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ambrisentan NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Ambrisentan suppliers with NDC on PharmaCompass.

    Ambrisentan GMP

    Ambrisentan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Ambrisentan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ambrisentan GMP manufacturer or Ambrisentan GMP API supplier for your needs.

    Ambrisentan CoA

    A Ambrisentan CoA (Certificate of Analysis) is a formal document that attests to Ambrisentan's compliance with Ambrisentan specifications and serves as a tool for batch-level quality control.

    Ambrisentan CoA mostly includes findings from lab analyses of a specific batch. For each Ambrisentan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Ambrisentan may be tested according to a variety of international standards, such as European Pharmacopoeia (Ambrisentan EP), Ambrisentan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ambrisentan USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search